Interleukin-6 in neuro-Behçet’s disease: Association with disease subsets and long-term outcome
Authors:
- Gülşen Akman-DemirGAGülşen Akman-Demir
- Erdem TüzünETErdem Tüzün
- Sema İçözSISema İçöz
- Nilüfer YeşilotNYNilüfer Yeşilot
- Sibel P. YentürSYSibel P. Yentür
- Murat KürtüncüMKMurat Kürtüncü
- Melike MutluMMMelike Mutlu
- Güher Saruhan-DireskeneliGSGüher Saruhan-Direskeneli
Abstract
No abstract availableKeywords
This publication has 22 references indexed in Scilit:
- Effect of infliximab in progressive Neuro-Behçet's syndromeJournal of the Neurological Sciences, 2008
- Headache in Behçet's DiseaseCephalalgia, 2006
- Serum interleukin‐6, procalcitonin and C‐reactive protein levels in subjects with active Behçet's diseaseJournal of the European Academy of Dermatology and Venereology, 2004
- Cytokines and chemokines in neuro-Behçet's disease compared to multiple sclerosis and other neurological diseasesJournal of Neuroimmunology, 2003
- Cytokine profile in Behçet's disease patientsScandinavian Journal of Rheumatology, 2002
- Clinical patterns of neurological involvement in Behçet's disease: evaluation of 200 patientsBrain, 1999
- Cerebrospinal Fluid Interleukin-6 in Progressive Neuro-Behçet's SyndromeClinical Immunology and Immunopathology, 1997
- Interleukin-6 (IL-6) in patients with Behçet's diseaseJournal of Dermatological Science, 1996
- Elevated levels of interleukin‐6 in cerebrospinal fluid from patients with systemic lupus erythematosus and central nervous system invol vementArthritis & Rheumatism, 1990
- Analysis of interleukin‐2 activity in patients with Behçet's disease. Ability of T cells to produce and respond to interleukin‐2Arthritis & Rheumatism, 1986